WallStreetZenWallStreetZen

NASDAQ: VRAX
Virax Biolabs Group Ltd Stock Ownership - Who owns Virax Biolabs Group?

Insider buying vs selling

Have Virax Biolabs Group Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when VRAX insiders and whales buy or sell their stock.

VRAX Shareholders

What type of owners hold Virax Biolabs Group Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC6.73%121,999$91.50kInstitution
Virtu Financial LLC0.59%10,644$7.98kInstitution
Ubs Group Ag0.04%665$498.75Institution
Wells Fargo Company0.01%200$150.00Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

VRAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VRAX7.37%0.00%
GLMD13.65%0.00%
ADTX0.09%99.91%Net Selling
TENX7.69%92.31%
BPTS0.00%0.00%

Virax Biolabs Group Stock Ownership FAQ

Who owns Virax Biolabs Group?

Virax Biolabs Group (NASDAQ: VRAX) is owned by 7.37% institutional shareholders, 0.00% Virax Biolabs Group insiders, and 92.63% retail investors. Armistice Capital LLC is the largest individual Virax Biolabs Group shareholder, owning 121,999.00 shares representing 6.73% of the company. Armistice Capital LLC's Virax Biolabs Group shares are currently valued at $86.01k.

If you're new to stock investing, here's how to buy Virax Biolabs Group stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.